Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Daria Marley Kemp, Alyson Pidich, Mary Larijani, Rebecca Jonas, Elizabeth Lash, Takami Sato, Mizue Terai, Maria De Pizzol, Marcello Allegretti, Olga Igoucheva, Vitali Alexeev
Published Jan 24, 2017 · Vol. 8, No. 9 · pp. 14428-14442
Edward T. Bagu, Sayem Miah, Chenlu Dai, Travis Spriggs, Yetunde Ogunbolude, Erika Beaton, Michelle Sanders, Raghuveera K. Goel, Keith Bonham, Kiven E. Lukong
Published Jan 6, 2017 · Vol. 8, No. 7 · pp. 11442-11459
Dieuwertje E.G. Kok, Lambertus A.L.M. Kiemeney, Gerald W. Verhaegh, Jack A. Schalken, Emile N.J.T. van Lin, J.P. Michiel Sedelaar, J. Alfred Witjes, Christina A. Hulsbergen - van de Kaa, Pieter van ’t Veer, Ellen Kampman, Lydia A. Afman
Published Jan 6, 2017 · Vol. 8, No. 6 · pp. 10565-10579